Dongwha Pharm.Co.Ltd (000020) - Total Liabilities

Latest as of June 2026: ₩238.21 Billion KRW ≈ $161.43 Million USD

Based on the latest financial reports, Dongwha Pharm.Co.Ltd (000020) has total liabilities worth ₩238.21 Billion KRW (≈ $161.43 Million USD) as of June 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore Dongwha Pharm.Co.Ltd long-term investment allocation to see how much of total assets are deployed in long-term investments.

Dongwha Pharm.Co.Ltd - Total Liabilities Trend (2011–2025)

This chart illustrates how Dongwha Pharm.Co.Ltd's total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see Dongwha Pharm.Co.Ltd assets under control.

Dongwha Pharm.Co.Ltd Competitors by Total Liabilities

The table below lists competitors of Dongwha Pharm.Co.Ltd ranked by their total liabilities.

Company	Country	Total Liabilities
Tongyang KO:001520	Korea	₩689.99 Billion
Tae Kyung Ind KO:015890	Korea	₩389.24 Billion
AlzeCure Pharma ST:ALZCUR	Sweden	Skr15.93 Million
GENOR BIOPHARMA DL-00002 F:67N0	Germany	€226.09 Million
Vertical Aerospace Ltd NYSE:EVTL	USA	$128.35 Million
GIIB Holdings Bhd KLSE:7192	Malaysia	RM67.48 Million
Tethys Petroleum Ltd V:TPL	Canada	CA$34.49 Million
Anixa Biosciences Inc NASDAQ:ANIX	USA	$1.87 Million

Liability Composition Analysis (2011–2025)

This chart breaks down Dongwha Pharm.Co.Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See Dongwha Pharm.Co.Ltd (000020) net asset quality to measure how much of total assets are equity-financed.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	1.22	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.60	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.36	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Dongwha Pharm.Co.Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Dongwha Pharm.Co.Ltd (2011–2025)

The table below shows the annual total liabilities of Dongwha Pharm.Co.Ltd from 2011 to 2025.

Year	Total Liabilities	Change
2025-12-31	₩240.73 Billion ≈ $163.14 Million	+10.45%
2024-12-31	₩217.96 Billion ≈ $147.71 Million	+38.02%
2023-12-31	₩157.92 Billion ≈ $107.02 Million	+91.50%
2022-12-31	₩82.46 Billion ≈ $55.88 Million	-5.94%
2021-12-31	₩87.67 Billion ≈ $59.41 Million	-3.79%
2020-12-31	₩91.13 Billion ≈ $61.75 Million	+21.25%
2019-12-31	₩75.15 Billion ≈ $50.93 Million	+2.67%
2018-12-31	₩73.20 Billion ≈ $49.61 Million	+4.15%
2017-12-31	₩70.28 Billion ≈ $47.63 Million	-1.95%
2016-12-31	₩71.68 Billion ≈ $48.58 Million	-17.68%
2015-12-31	₩87.07 Billion ≈ $59.01 Million	+4.47%
2014-12-31	₩83.35 Billion ≈ $56.48 Million	-6.28%
2013-12-31	₩88.93 Billion ≈ $60.27 Million	-8.59%
2012-12-31	₩97.29 Billion ≈ $65.93 Million	-11.40%
2011-12-31	₩109.81 Billion ≈ $74.42 Million	--

About Dongwha Pharm.Co.Ltd

KO:000020 Korea Drug Manufacturers - Specialty & Generic

Market Cap

$93.92 Million

₩138.59 Billion KRW

Market Cap Rank

#19509 Global

#986 in Korea

Share Price

₩5000.00

Change (1 day)

-0.20%

52-Week Range

₩4550.00 - ₩6670.00

All Time High

₩28554.43